Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants
Clinical trial NCT02221180 · COMPLETED
Trial details
- NCT number
- NCT02221180
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2014-11-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.